Literature DB >> 34003788

Mdm2 and MdmX: Partners in p53 Destruction.

James J Manfredi1.   

Abstract

Mdm2 and MdmX are two closely related proteins that have been well-characterized as negative regulators of the tumor suppressor p53. Their interplay and especially respective roles in ubiquitination and subsequent degradation of p53 have lacked clarity. Yang and colleagues now demonstrate an obligate role for MdmX in recruitment of the E2 ubiquitin ligase UbcH5c to the Mdm2-MdmX hetero-oligomer. The use of elegant genetically engineered mouse models ensures the biological relevance of their findings that have important implications for targeted therapies involving these key players in the p53 pathway.See related article by Yang et al., Cancer Res 2021;81:898-909. ©2021 American Association for Cancer Research.

Entities:  

Year:  2021        PMID: 34003788     DOI: 10.1158/0008-5472.CAN-21-0145

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  3 in total

Review 1.  Therapeutics Targeting p53-MDM2 Interaction to Induce Cancer Cell Death.

Authors:  Nayeong Koo; Arun K Sharma; Satya Narayan
Journal:  Int J Mol Sci       Date:  2022-04-30       Impact factor: 6.208

2.  Therapeutic synergy of Triptolide and MDM2 inhibitor against acute myeloid leukemia through modulation of p53-dependent and -independent pathways.

Authors:  Qinwei Chen; Suqi Deng; Manman Deng; Yuanfei Shi; Mengya Zhong; Lihong Ding; Yuelong Jiang; Yong Zhou; Bing Z Carter; Bing Xu
Journal:  Exp Hematol Oncol       Date:  2022-04-16

3.  Glaucocalyxin A Inhibits the Malignancies of Gastric Cancer Cells by Downregulating MDM2 and RNF6 via MiR-3658 and the SMG1-UPF mRNA Decay Pathway.

Authors:  Yanqi Liu; Ping Chen; Daqing Qi; Linhui Chen
Journal:  Front Oncol       Date:  2022-06-22       Impact factor: 5.738

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.